VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TARA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TARAProtara Therapeutics, Inc.
$2.30$129M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTARAQuarterly Balance Sheet

Protara Therapeutics, Inc. (TARA) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Protara Therapeutics, Inc. (TARA) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

TARA Balance Sheet

Quarterly statement

TARA Balance Sheet

Protara Therapeutics, Inc. (TARA) balance sheet — 14-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets129.67M146.15M140M159.5M135.64M125.09M126.53M172.16M85.08M92.21M57.91M68.7M77.81M84.27M94.62M86.15M98.67M101.09M90.69M93.11M
Cash & Short-Term Investments127.05M17.08M135.79M155.55M132.67M122.22M124.36M170.29M81.5M89.58M55.22M65.58M74.03M80.36M86.61M84.37M96.32M98.46M87.59M91.23M
Cash Only25.15M17.08M14.74M49.66M12.55M31.5M91.46M162.8M51.76M89.58M52.23M39.59M33.77M33.98M21.04M24.13M47.5M33.81M25.44M35.72M
Short-Term Investments101.9M0121.05M105.9M120.12M90.72M32.9M7.49M29.74M02.99M25.99M40.27M46.38M65.58M60.24M48.82M64.64M62.16M55.51M
Accounts Receivable001.52M1.26M1M890K368K00023K242K0344K0486K0487K00
Days Sales Outstanding--------------------
Inventory0000000000000001.16M0000
Days Inventory Outstanding--------------------
Other Current Assets2.62M125.42M17K65K218K78K16K2K3K1.58M3K37K3.19M1K6.87M-1.04M1.33M0995K1.35M
Total Non-Current Assets26.87M29.94M51.93M49.96M8.99M31.84M42.03M9.3M9.01M9.43M10.22M10.25M10.65M10.88M11.79M27.14M49.92M53.79M70.57M79.48M
Property, Plant & Equipment3.89M3.92M3.56M3.93M4.28M4.64M4.98M5.28M5.62M5.95M6.23M6.56M6.97M7.25M7.57M7.87M8.17M8.37M8.63M8.89M
Fixed Asset Turnover--------------------
Goodwill000000000000000029.52M29.52M29.52M29.52M
Intangible Assets005.9M2.93M2.99M3.04M3.11M3.25M2.54M2.58M2.63M2.66M00084K0000
Long-Term Investments0041.64M42.34M957K23.39M33.15M00745K000745K2.89M17.89M10.76M14.35M30.89M39.47M
Other Non-Current Assets22.98M26.02M821K765K766K774K780K772K846K155K1.36M1.03M3.69M2.88M1.33M1.3M1.48M1.56M1.53M1.61M
Total Assets156.54M176.09M191.92M209.47M144.64M156.93M168.56M181.45M94.09M101.65M68.13M78.95M88.47M95.14M106.41M113.29M148.59M154.88M161.26M172.6M
Asset Turnover--------------------
Asset Growth %8.23%12.21%13.86%15.44%53.72%54.39%147.39%129.82%6.36%6.84%-35.97%-30.31%-40.46%-38.57%-34.01%-34.36%-17.77%-18%-16.19%-15.04%
Total Current Liabilities14.39M13.32M8.92M10.94M9.91M9.76M7.02M10.96M8.64M5.65M5.5M6.15M6.78M4.93M6.41M5.74M3.71M3.49M2.86M4.3M
Accounts Payable4.86M4.66M4.03M3.47M4.5M5.3M2.31M4.43M2.29M1.39M972K2.43M2.5M1.85M4.08M1.59M456K392K541K954K
Days Payables Outstanding--3.75K-------1.87K---------
Short-Term Debt1.31M000000000000949K000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities13.08M01.09M3.27M2.24M1.48M680K2.53M1.51M999K1.06M2.11M01.03M02.54M0052K0
Current Ratio9.01x10.97x15.69x14.58x13.69x12.82x18.03x15.71x9.85x16.33x10.53x11.17x11.49x17.09x14.76x15.01x26.59x28.94x31.70x21.66x
Quick Ratio9.01x10.97x15.69x14.58x13.69x12.82x18.03x15.71x9.85x16.33x10.53x11.17x11.49x17.09x14.76x14.81x26.59x28.94x31.70x21.66x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities1.13M1.46M1.79M2.12M2.44M2.75M3.06M3.36M3.66M3.95M4.23M4.48M4.74M4.98M5.23M5.47M5.7M5.93M6.16M6.38M
Long-Term Debt1.13M01.79M00000000000000000
Capital Lease Obligations01.46M02.12M2.44M2.75M3.06M3.36M3.66M3.95M4.23M4.48M4.74M4.98M5.23M5.47M5.7M5.93M6.16M6.38M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities00000000000000000000
Total Liabilities15.52M14.78M10.71M13.06M12.35M12.51M10.07M14.32M12.3M9.6M9.73M10.63M11.51M9.92M11.64M11.21M9.41M9.43M9.02M10.68M
Total Debt2.44M2.75M3.06M3.36M3.66M3.95M4.23M4.48M4.74M4.98M5.23M5.47M5.7M5.93M6.16M6.38M6.6M6.82M7.03M7.24M
Net Debt-22.71M-14.33M-11.68M-46.3M-8.89M-27.55M-87.23M-158.31M-47.02M-84.6M-47M-34.12M-28.07M-28.05M-14.88M-17.74M-40.9M-27M-18.41M-28.48M
Debt / Equity0.02x0.02x0.02x0.02x0.03x0.03x0.03x0.03x0.06x0.05x0.09x0.08x0.07x0.07x0.07x0.06x0.05x0.05x0.05x0.04x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-15.79x---------------93.38x-27.07x-23.68x-25.23x-
Total Equity141.02M161.31M181.21M196.41M132.29M144.42M158.48M167.13M81.79M92.05M58.41M68.32M76.96M85.22M94.77M102.08M139.18M145.46M152.24M161.91M
Equity Growth %6.6%11.69%14.34%17.52%61.74%56.9%171.35%144.63%6.28%8.01%-38.37%-33.07%-44.71%-41.41%-37.75%-36.95%-18.33%-18.47%-19.08%-18.74%
Book Value per Share2.242.643.154.273.133.423.896.323.664.345.116.016.787.548.389.0612.3512.9213.5314.41
Total Shareholders' Equity141.02M161.31M181.21M196.41M132.29M144.42M158.48M167.13M81.79M92.05M58.41M68.32M76.96M85.22M94.77M102.08M139.18M145.46M152.24M161.91M
Common Stock60K59K55K54K39K39K39K35K21K21K11K11K11K11K11K11K11K11K11K11K
Retained Earnings-363.56M-341.87M-320.2M-302.42M-285.11M-271.85M-256.89M-244.98M-232.21M-220.99M-211.48M-200.38M-190.16M-180.3M-169.01M-159.96M-121M-113.31M-104.77M-94.01M
Treasury Stock00000000000000000000
Accumulated OCI-550K-363K-364K90K143K77K89K2K29K0-1K-31K-165K-336K-469K-688K-1.13M-1.12M-942K-211K
Minority Interest00000000000000000000